Evidence map›Paper›PMID 40093656›Full record

ArticlePhysics and imaging in radiation oncology2025

Development and comprehensive clinical validation of a deep neural network for radiation dose modelling to enhance magnetic resonance imaging guided radiotherapy.

Moritz Schneider, Simon Gutwein, David Mönnich, Cihan Gani, Paul Fischer, Christian F Baumgartner, Daniela Thorwarth

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Moritz SchneiderSection for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
Simon GutweinSection for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
David MönnichSection for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
Cihan GaniDepartment of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
Paul FischerCluster of Excellence "Machine Learning: New Perspectives for Science", University of Tübingen, Germany.
Christian F BaumgartnerCluster of Excellence "Machine Learning: New Perspectives for Science", University of Tübingen, Germany.
Daniela ThorwarthSection for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Online adaptive magnetic resonance imaging (MRI)-guided radiotherapy requires fast dose calculation algorithms to reduce intra-fraction motion uncertainties and improve workflow efficiency. While Monte-Carlo simulations are precise but computationally intensive, neural networks promise fast and accurate dose modelling in strong magnetic fields. This study aimed to train and evaluate a deep neural network for dose modelling in MRI-guided radiotherapy using a comprehensive clinical dataset. Materials and methods: A dataset of 6595 clinical irradiation segments from 125 1.5 T MRI-Linac radiotherapy plans for various tumors sites was used. A 3D U-Net was trained with 3961 segments using 3D imaging data and field parameters as input, Root Mean Squared Error and a custom loss function, with full Monte-Carlo simulations as ground truth. For 2656 segments from 50 patients, gamma pass rates (γ-PR) for 3 mm/3%, 2 mm/2%, and 1 mm/1% criteria were calculated to assess dose modelling accuracy. Performance was also tested in a standardized water phantom to evaluate basic radiation physics properties. Results: The neural network accurately modeled dose distributions in both patient and water phantom settings. Median (range) γ-PR of 97.7% (87.5-100.0%), 89.1% (69.7-99.4%), and 60.8% (38.5-82.1%) were observed for treatment plans, and 97.1% (55.5-100.0%), 88.8% (38.8-99.7%), and 61.7% (17.9-94.4%) for individual segments, across the three criteria. Conclusion: High median γ-PR and accurate modelling in both water phantom and clinical data demonstrate the high potential of neural networks for dose modelling. However, instances of lower γ-PR highlight the need for comprehensive test data, improved robustness and future built-in uncertainty estimation.

Indexed as

Artificial intelligenceDose calculationMRI-guided radiotherapyOnline adaptive radiotherapy

Identifiers

PMID40093656
PMCPMC11908596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.